• Assessment of Adhesion Response To 3D Printed Materials For Ophthalmic Device Development

    Nov 1, 2016, 00:00

  • Parametric and Non-Parametric Approaches for Predicting Bacterial Resistance

    Nov 1, 2016, 00:00

  • A Comparison of Insulin Degludec Clinical Evaluations and Recommendations Between an Independent HTA and National HTA Bodies

    Nov 1, 2016, 00:00

  • Eltrombopag Vs Romiplostim In Adult Patients With Chronic Immune Trombocytopenia- Economic Evaluation

    Nov 1, 2016, 00:00

  • How much do the insured citizens know about the personal account of china's urban employees' basic medical insurance and what are their needs? Evidence from guizhou, china

    Nov 1, 2016, 00:00

  • An Indirect Comparison Between Adalimumab, Baricitinib And Tofacitinib For The Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Effects of A Chronic Obstructive Pulmonary Disease Integrated Care Pathway Programme in Singapore

    Nov 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts For Pharmaceutical Innovations In Germany When Price Negations Between Payors And Manufacturers Fail- An Empirical Analysis Of 5 Years' Experience

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv)- A Systematic Literature Review (Slr) Using Rapid Review Methodology

    Nov 1, 2016, 00:00

  • Drug Use Analysis of Patients with Hypertension and Diabetes in Shanghai, China- Based on Drug Bidding Database of Shanghai Medical Instituions

    Nov 1, 2016, 00:00

  • Cost–Effectiveness of Different Strategies for Prevention of Venous Thromboembolism after Total Hip Replacement in China

    Nov 1, 2016, 00:00

  • Patient Information And Consent Form In Europe- Requirements From Regulatory Authorities For Pharmaco-Epidemiological Studies

    Nov 1, 2016, 00:00

  • Decision Uncertainty and Need for Further Research- A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

    Nov 1, 2016, 00:00

  • Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design- An Example in A Rare Cardiac Clinical Trial

    Nov 1, 2016, 00:00

  • Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In Portugal

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

    Nov 1, 2016, 00:00

  • The Prescribing, Inpatient, Outpatient and Social Care Costs Associated with Atrial Fibrillation in Scotland- A Record Linkage Study

    Nov 1, 2016, 00:00

  • Predictors of Disease Progression in Mild Alzheimer’s Disease Dementia Patients – Results From the Geras Real World Cohort and Expedition Trials

    Nov 1, 2016, 00:00

  • Construction of System Dynamics Model for Medical Care System of Japan

    Nov 1, 2016, 00:00

  • Health Related Quality of Life In The Deaf British Signing Population

    Nov 1, 2016, 00:00

  • Stroke Treatment Cost Analysis for Consideration on Health Cost Determination Using INA-CBG'S (Indonesia Case Based Groups) in Indonesia National Health Insurance Programme 2014

    Nov 1, 2016, 00:00

  • Assessment of Health Related Quality of Life (Hrqol) of Patients with Severe Mental Illness Attending Tertiary Care Public Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • The Choice of A Fluoropyrimidine Regimen in Patients with Advanced Colorectal Cancer

    Nov 1, 2016, 00:00

  • Trans-Pacific Partnership Agreement And Its Impact On Accessibility And Affordability Of Medicines- A Meta-Synthesis

    Nov 1, 2016, 00:00

  • Literature Review of Studies Evaluating Cost Effectiveness of Prostaglandins and ß-Blockers in Primary Open Angle Glaucoma Patients

    Nov 1, 2016, 00:00

  • Identifying Patient Reported Signs and Symptoms of Being Overweight and Obese

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sequential USE of ELF/ARFI Test Versus Biopsy to Assess Liver Fibrosis in Chronic HCV

    Nov 1, 2016, 00:00

  • The Road to Russian Pharmacoeconomics- Understanding the Drivers for Access to High-Value / Orphan Disease Drugs

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

    Nov 1, 2016, 00:00

  • Comparison Between Eq-5d And Hui In Japanese Population Norms

    Nov 1, 2016, 00:00

  • Self-Efficacy And Health Behaviors Impact Quality Of Life Of Elderly Along Eastern Sea Coast Of Thailand 2015

    Nov 1, 2016, 00:00

  • The Burden of Severe Asthma in France

    Nov 1, 2016, 00:00

  • Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

    Nov 1, 2016, 00:00

  • Future Disparities Between Demand And Supply of Tertiary Emergency Care In Regions Affected By The Great East Japan Earthquake

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Acarizax® In Patients with House Dust Mites Induced Allergic Asthma And Allergic Rhinitis In Slovakia

    Nov 1, 2016, 00:00

  • Measuring Of The Uncertainty In Reimbursement System For Medicinal Products

    Nov 1, 2016, 00:00

  • Economic Burden of Stroke- A Systematic Review on Post-Stroke Care

    Nov 1, 2016, 00:00

  • Patient Perspectives on Merkel Cell Carcinoma (MCC) and Its Treatment with A Novel Agent (AVELUMAB)- Findings From In-Depth Qualitative Patient Interviews

    Nov 1, 2016, 00:00

  • Psoriatic Arthritis is Associated with A Greater Economic and Humanistic Burden Among Patients with Psoriasis- Results from A Multinational Physician and Patient Survey

    Nov 1, 2016, 00:00

  • Cost of Illness Study In Patients With Myasthenia Gravis Treated With Plasma Exchange Therapy In Belgium

    Nov 1, 2016, 00:00

  • The Patient Journey After A Diagnosis of Early/Locally Advanced Breast CA In Greece And Choice of Provider

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Asia-Pacific (APAC) Markets- Systematic Evaluation in 10 APAC Countries

    Nov 1, 2016, 00:00

  • Use of Data-Mining to Perform a Real World Cost Analysis of Her2-Positive Breast Cancer In Iran

    Nov 1, 2016, 00:00

  • How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?

    Nov 1, 2016, 00:00

  • A Quantitative Analysis of Health Technology Assessment (HTA) Agencies for Attributes Driving Transparency of the Organization- Comparison of Six Asia-Pacific HTA Agencies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk- A Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Health State Valuation in Sri Lanka Using the EQ-5D-3l; Precursor to Qaly Estimation in South Asia

    Nov 1, 2016, 00:00

  • Trend in HBA1C Levels Among Primary Care Diabetes Patients Admitted to a Tertiary Hospital in Singapore in 2013

    Nov 1, 2016, 00:00

  • When Cost Saving Technologies are Not Adopted Despite Evidence and Payer Recommendations – Intraoperative Fluid Management (IOFM) in the UK

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Hodgkin's Lymphoma Following Autologous Stem Cell Transplant in Taiwan

    Nov 1, 2016, 00:00

  • The Cost of Hypercholesterolaemia in Ireland

    Nov 1, 2016, 00:00

  • Current Practice and Attitude Regarding off-Label Drug Use- A Survey of Oncology Practitioners

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge And Practice Regarding Foot Care Of Diabetes Mellitus Patient In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Prediction Of Costs Associated With The Hospital Management Of Hiv Patients In France Using An Advanced Data Mining Approach On The French Medical Information System Database

    Nov 1, 2016, 00:00

  • What is the Most Cost-Effective Way to Set-Up Organised Cervical Cancer Screening in France? A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Hospitalized Patients with Schizophrenia In Portugal- Clinical Characterization and Costs

    Nov 1, 2016, 00:00

  • Treatment Cost Estimation of Chronic Gastritis Caused by Helicobacter Pylori

    Nov 1, 2016, 00:00

  • Impact of Potential Drug Interactions in Cardiac Patients on Morbidity Risk- An Observational Prospective Approach

    Nov 1, 2016, 00:00

  • Trend Of Pharmacoeconomics And Health Outcome Studies In Turkey

    Nov 1, 2016, 00:00

  • The 2016 US Payor Landscape- Results from a Survey of Medical and Pharmacy Directors on Formulary Management

    Nov 1, 2016, 00:00

  • Real World Data on the Adherance to the National Policy of Integrative and Complementary Practices in the Brazilian Unified Health System - The Acupuncture Case

    Nov 1, 2016, 00:00

  • Patients' Educational Background was Associated with the Validity and Reliability of a Health-Related Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Evaluate The Efficacy of Ixekizumab In The Treatment of Moderate-To-Severe Psoriasis

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Burden of Wolfram Syndrome In The United Kingdom

    Nov 1, 2016, 00:00

  • Economic Benefits of Cpap Treatment for Obstructive Sleep Apnea in The Elderly

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain

    Nov 1, 2016, 00:00

  • The Reduction Of Ceiling With The Eq-5d-5l Increases With Age In The General Adult Population

    Nov 1, 2016, 00:00

  • Quantification Of Quality Of Life Differences Due To Common Diseases In The Age Group 50+ In The United Kingdom

    Nov 1, 2016, 00:00

  • A Systematic Review of Tyrosine Kinase Inhibitors as First Line Treatment for Advanced Non Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Multi-Criteria Assessment In HTA Process in the Czech Republic- the Role of Different Stakeholders Involvement and Impact on Appraisal of Drugs Including Orphans

    Nov 1, 2016, 00:00

  • Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment

    Nov 1, 2016, 00:00

  • Beware the Impact of Discount Rates in the Assessment of HPV Vaccines

    Nov 1, 2016, 00:00

  • Understanding the Impact of Laboratory Performance on Outcomes in a Screening Population for Cardiovascular Disease in Taiwan

    Nov 1, 2016, 00:00

  • The Burden of Staple Line Interventions in Colorectal Surgery Europe

    Nov 1, 2016, 00:00

  • Management of Children's Acute Diarrhea by Community Pharmacies in Five Towns of Ethiopia- Simulated Client Case

    Nov 1, 2016, 00:00

  • Pharmacotherapy Consultations By Clinical Pharmacists To Improve Quality And Safe Use Of Medicines- An Experience From Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Need for Enhanced Glucose Screening in Pregnant Women in Indonesia

    Nov 1, 2016, 00:00

  • Screening Rate for Diabetic Retinopathy and Macular Edema in Patients with Diabetes and their Treatment Costs in the United Arab Emirates

    Nov 1, 2016, 00:00

  • THE IMPACT OF THE ECONOMIC CRISIS ON THE INCIDENCE AND INTENSITY OF CATASTROPHIC HEALTH PAYMENTS IN GREECE

    Nov 1, 2016, 00:00

  • Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Accelerated/Malignant Hypertension with a Diagnostic Ambugity- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • Antithrombotic Treatment Pattern in Patients with Atrial Fibrillation in Italy Before and After Xaban/Dtis Launch- The Repair Study Cross-Sectional Results

    Nov 1, 2016, 00:00

  • Age and Gender Specific Trends in Acute Inpatient Stroke Incidence in Germany

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis Of Baofukang Versus Langyi In The Treatment Of Vvc

    Nov 1, 2016, 00:00

  • Determinants of Orphan Drug Prices in Italy and the UK

    Nov 1, 2016, 00:00

  • The European Social Preference Measurement (ESPM) Study- Conceptual Considerations and Implementation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Type 2 Diabetes (T2DM) Treatment with Dapagliflozin as Add-On to Metformin in the Dominican Republic and Guatemala

    Nov 1, 2016, 00:00

  • Time and Cost of Hospitalization for Salvage Therapy Among Adults with Philadelhphia (PH)-Negative B-Cell Relapsed/Refractory (R/R) Acute Lymphoblastic Leukaemia (ALL) In Spain

    Nov 1, 2016, 00:00

  • Increased Use of Effective Non-Cancer Drugs Following Removal of Benefit Caps Among Cancer Patients In Medicaid- A Quasi-Experimental Study

    Nov 1, 2016, 00:00

  • Increasing Efficiency of Pricing and Market Access Decisions By Cross Functional Interactions

    Nov 1, 2016, 00:00

  • The Cost of Asthma In Italy

    Nov 1, 2016, 00:00

  • Systemic Adverse Drug Reactions of Antihypertensive Agents

    Nov 1, 2016, 00:00

  • Economic Evaluation of Diacerein, Diclofenac and Glucosamine for Osteoarthritis in China

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Exercise for the Prevention of Cancer

    Nov 1, 2016, 00:00

  • Economic Analyses of Flair® and Fluency® Plus Endovascular Stent Grafts for the Treatment of Vascular Access Stenosis- A U.S. Hospital and Payer Perspective

    Nov 1, 2016, 00:00

  • Impact of Animal Testing on Mental Health of Researchers

    Nov 1, 2016, 00:00

  • A Time Series Analysis of Social Insurance and Patient Costs of Reimbursed Medical AIDS in Hungary

    Nov 1, 2016, 00:00

  • Survival and Resource use in The Treatment of Metastatic Renal Cell Carcinoma in Sweden- A Retrospective Analysis of Data from National Registries

    Nov 1, 2016, 00:00

  • Variation of Data Source Used for Baseline Population and for Natural Course of Alzheimer's Disease Progression in Model-Based Economic Evaluation of Treatment of AD

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Pasireotide Long-Acting Compared To Continued Use of A First-Line Somatostatin Antagonist For The Treatment of Acromegaly In Sweden

    Nov 1, 2016, 00:00

  • How is Radiotherapy Reimbursed Across Europe? Results of The Health Economics in Radiation Oncology’s Survey

    Nov 1, 2016, 00:00

  • Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

    Nov 1, 2016, 00:00

  • Diabetes Self-Management- Pharmacy Perspective

    Nov 1, 2016, 00:00

  • Treatment of Osteochondral Fracture and Medial Patellofemoral Ligament Rupture After Patellar Dislocation

    Nov 1, 2016, 00:00

  • Health Technology Assessment of the use Vaccines for Prevention Flu

    Nov 1, 2016, 00:00

  • The Association Between Loneliness and Healthcare Utilization Among Older Adults in Singapore

    Nov 1, 2016, 00:00

  • An Assessment of The Relative Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors As Add-On To Metformin In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Investigating Influenza Vaccinations for Risk Groups in Ukraine

    Nov 1, 2016, 00:00

  • Consolidation of China's Two Basic Medical Insurance Programs- Understanding New Opportunities for Access

    Nov 1, 2016, 00:00

  • Adverse Events Associated with Intravenous Immunoglobulin in Thailand

    Nov 1, 2016, 00:00

  • Costs, Outcomes And Uses Of New Drugs- Drug Assessment Reports Vs Real World Data

    Nov 1, 2016, 00:00

  • The Evolution of Risk-Sharing Agreements in the Process of Updating the National List of Health Services in Israel

    Nov 1, 2016, 00:00

  • Severe Sepsis In Adults- Impact of Diagnostic Coding on Hospital Resource Utilization

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Direct Medical Resource Utilization For Reoperation After Intramedullary Fixation of Pertrochanteric HIP Fractures

    Nov 1, 2016, 00:00

  • Retrospective Database Study Describing Patient Characteristics And Resource Use in Swedish Patients Receiving Second Generation Long Acting Injection Antipsychotics

    Nov 1, 2016, 00:00

  • ‘Severe Illness Insurance' in China- Impact of the New Coverage on Access to Health Care and Innovative Drugs

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis to Estimate The Economic Consequences Of Introducing The Combination of Avastin + Tarceva for The Treatment of First Line Epidermal Growth Factor (EGFR) Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Nintedanib Plus Docetaxel as Second-Line Therapy in Patients with Non-Small-Cell Lung Cancer (NSCLC)- A Network Meta-Analysis vs. New Therapeutic Options

    Nov 1, 2016, 00:00

  • Evaluation of Health Care Costs and Utilization Patterns for Patients with Gout in Taiwan

    Nov 1, 2016, 00:00

  • Iatrogenic Hypoglycaemia in the Elderly- An Analysis of Diabetic Medication Usage Patterns According to Age

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis to Evaluate the Femtosecond Laser-Assisted Cataract Surgery in Children

    Nov 1, 2016, 00:00

  • Use of A Claims Database To Document The Use and Effectiveness of Oral Vinorelbine (NVBO) in A Real World Setting France

    Nov 1, 2016, 00:00

  • Which Types of Economic Evaluations are Considered by Health Technology Assessment Agencies?

    Nov 1, 2016, 00:00

  • Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices in Germany

    Nov 1, 2016, 00:00

  • Using Evidence Reviews To Develop Focused Systematic Review Questions

    Nov 1, 2016, 00:00

  • Work Productivity and use of Disease-Modifying Therapies in Multiple Sclerosis- Results From A Patient Survey Accessed Through Social Media

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

    Nov 1, 2016, 00:00

  • Budget Impact Of Ulipristal Acetate 5mg In Pre-Operative Treatment Of Uterine Fibroids- An Analysis Based On Public Data On Hospital Stays In France

    Nov 1, 2016, 00:00

  • Early Indicators of Patients with Major Depressive Disorder in Need of Highly Specialized Care- A Systematic Review

    Nov 1, 2016, 00:00

  • The Impact of Rifaximin-A on Non-Elective Hospital Admission and Attendance Costs in Uk Patients with Hepatic Encephalopathy

    Nov 1, 2016, 00:00

  • A Systematic Review On The Epidemiology of NRAS-Mutant Melanoma in Europe and Australia

    Nov 1, 2016, 00:00

  • Translation And Validation Of Condition-Specific Quality Of Life Pfdi-20 And Pfiq-7 Questionnaires For Women With Pelvic Floor Dysfunction In The Norwegian Context

    Nov 1, 2016, 00:00

  • Annual Cost and Effects of Switching to Insulin Degludec from Other Basal Insulins- Evidence from Swedish Real-World Data

    Nov 1, 2016, 00:00

  • Determining The Clinical Practice And Resource Use Associated To The Diagnosis And Treatment Of Clostridium Difficile Infection In Mexico

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Health State Utility Values in Mulitple Myeloma

    Nov 1, 2016, 00:00

  • Virtual Planning and Patient-Specific Implants in Mandibular Reconstructionsurgery- A Micro-Costing Analysiss

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment For Chronic Obstructive Pulmonary Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Advanced Therapy Medicinal Products (Atmps) In Europe 8 Years On- What Is The Path To Market Access So Far?

    Nov 1, 2016, 00:00

  • Cardiovascular Safety of Saxagliptin In Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analysis

    Nov 1, 2016, 00:00

  • Measures Taken By The Romanian Ministry Of Health For Better Access To Anti-Egfr Drugs

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities Based on the Eq-5d in Studies of Lymphomas

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Time to Virologic Suppression in Treatment-Naive HIV-1 Patients- A Network Meta-Analysis of Longitudinal Data

    Nov 1, 2016, 00:00

  • Effects of Hbsag Positivity During Pregnancy on Adverse Maternal Outcomes- A Retrospective Database Analysis

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes - Patient Satisfaction With Selected Characteristics of Rehabilitation Medical Devices - Usage, Acquisition, offer, Range And Quality

    Nov 1, 2016, 00:00

  • Comparison of Cost-Effectiveness Between Egfr-Tkis Therapy and Chemotherapy for Advanced Nsclc

    Nov 1, 2016, 00:00

  • The Economic Value of Olmesartan for The Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • Analysing The Evolution of Cancer Drug Prices in France Since 2000

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland

    Nov 1, 2016, 00:00

  • Experiences And Attitudes Related To Screening of Patients Attended on A Colorectal Screening Pilot Program In Hungary

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • Quality of Life (QOL) and Health Utility (UT) in Patients with Type 2 Diabetes Mellitus (DM2) Receiving Different Oral Hypoglycemic Therapy in a Real-World Setting

    Nov 1, 2016, 00:00

  • Eq-5d Studies In Nervous System Diseases In Eight Central And Eastern European Countries

    Nov 1, 2016, 00:00

  • Choice of First Opioid Prescription and the Transitions from Acute to Long Term Opioid Use – Findings from Big Data

    Nov 1, 2016, 00:00

  • Cost-utility of nintedanib vs. Pirferidone in the treatment of idiopathic pulmonary fibrosis in spain

    Nov 1, 2016, 00:00

  • The Impact of Cancer Prevention and Treatment Policy on Increasing Incidence of Early-Stage Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Mepolizumab For The Treatment of Chronic Asthma. A Meta-Analysis of Randomized Placebo-Controlled Trials

    Nov 1, 2016, 00:00

  • Development of Antibiogram for Management of Aerobic Bacterial Infection in Diabetic Foot Ulcer

    Nov 1, 2016, 00:00

  • Secukinumab In The Management of Psoriatic Arthritis In Gree A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Preliminary Cost-Effectiveness Assessment of 3D Printed Anatomic Models for Congenital Heart Diseases

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The use of Rivaroxaban in Treatment of Venous Thromboembolism in Spain

    Nov 1, 2016, 00:00

  • Cost Minimization Of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii In Patients With A Nd B Hemophilia In Presence Of Inhibitors

    Nov 1, 2016, 00:00

  • Potential Cost Savings of A Point-Of-Care Diagnostic Test Measuring Antipsychotic Plasma Levels for Treatment of Patients with Schizophrenia in Spain

    Nov 1, 2016, 00:00

  • The 2012 Updated Beers Criteria in Falls Related Hospitalization in Older Adults

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Dimethyl Fumarate Versus Fingolimod And Teriflunomide In Patients With Relapsing-Remitting Multiple Sclerosis In Colombia

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Pharmacological Interventions For Preventing Migraine In Children And Adolescent- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Budget And Patient Access Analysis To Second Line Therapy Of Multiple Sclerosis In Bulgaria

    Nov 1, 2016, 00:00

  • Mapping The Policy Response To Breast Cancer In Asia

    Nov 1, 2016, 00:00

  • Response to Targeted Therapy and Healthcare Resource Utilization (HRU)- A European Retrospective Chart Review Study in Patients With HER2+ Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Patient Access to High-Cost and High-Value Specialty Products in China- Review of Decisions From Zhejiang, Neimenggu, Shandong and Jiangxi

    Nov 1, 2016, 00:00

  • Biosimilars And Reference Price Groups In Germany

    Nov 1, 2016, 00:00

  • Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Business Intelligence for Detecting Possible Surgical Site Infections from Gallbladder Surgery (Chol) and Colon Surgery (Colo) in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • Evaluating The Experiential Quality of Older People's Community Care- A Concept Mapping Approach To Instrument Design

    Nov 1, 2016, 00:00

  • Antiasthmatic Drug Prescribing Pattern Assessment at Medical Reimbursement in Employees Health Care Facility of Banaras Hindu University

    Nov 1, 2016, 00:00

  • A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Western Europe

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer- A Net-Benefit Regression Approach

    Nov 1, 2016, 00:00

  • Economic Burden of Rheumatoid Arthritis In Italy- Possible Consequences on Early Rapidly Progressing Patients

    Nov 1, 2016, 00:00

  • Reconsidering Drugs Funded Via The Cancer Drugs Fund in England- What’s New This Time?

    Nov 1, 2016, 00:00

  • Timing of Insulin Injections Predicts Type 2 Diabetes Control and Adherence in a Multinational Sample

    Nov 1, 2016, 00:00

  • A Systematic Review Comparing Studies of Cardiovascular Event Utilities by Geographic Region

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine (CAM) Disclosure to the Health Care Providers- A Qualitative Insight from Malaysia Thalassemia Patients

    Nov 1, 2016, 00:00

  • A Trial-Based Euroqol Eq-5d Health Utility Analysis in Patients with Previously Treated Advanced Nsclc

    Nov 1, 2016, 00:00

  • Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study

    Nov 1, 2016, 00:00

  • Cost Variations of Inpatient, Daycare and Outpatient Hysteroscopy in A Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • PCSK9 Inhibitors May Improve Cardiovascular Outcomes- Can We Afford Them?

    Nov 1, 2016, 00:00

  • Change Management of Polypharmacy and Adheren The Experience of Eu Simpathy Program

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Japan

    Nov 1, 2016, 00:00

  • Evaluation of Social Security Organization'(SSO) Regulations on Physician Prescribing Pattern in Iran in 2014

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Peg-L-Asparginase Versus E.Coli L-Asparaginase in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients- A Jordanian Perspective

    Nov 1, 2016, 00:00

  • Impact of Glucosamine on the Burden of Knee Osteoarthritis Over A 6 Month-Period in Fran An Observational Study

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Secukinumab In The Management of Ankylosing Spondylitis In Greece

    Nov 1, 2016, 00:00

  • Overview on Epidemiological Data For Multiple Myeloma In Austria

    Nov 1, 2016, 00:00

  • How do Migraines Impact Patient Day-To-Day life? An Exploratory Analysis of Patient Reported Data From The Patientslikeme Community

    Nov 1, 2016, 00:00

  • Current Trends in Methods of Pharmacoeconomic Studies of Cancer Therapies in China

    Nov 1, 2016, 00:00

  • The Relationship Between Regret In Patient Decision-Making During The Clinical Process And Patient Factors—Tests Based On The Japanese Version Of The Decision Regret Scale(Drs)—

    Nov 1, 2016, 00:00

  • Transcatheter Aortic Valve Implantation For Inoperable Severe Aortic Stenosis - A Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

    Nov 1, 2016, 00:00

  • Efficiency in Use of Lensx Vs Phacoemulsification Surgery for Cataract Treatment- Results from a Global Observational Study

    Nov 1, 2016, 00:00

  • Patient Individual Therapy as Appropriate Comparator in Amnog-Dossiers in The Field of Oncology- Status Quo and Strategic Implications For Pharmaceutical Companies

    Nov 1, 2016, 00:00

  • Assessment of Patient Preferences in the Treatment of Relapsing-Remitting Multiple Sclerosis in Public and Private Systems in Latin America

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis Of Different Health Policies Based On The Second Generation Daa-Ifn Free Regimens In An Italian Population

    Nov 1, 2016, 00:00

  • The Adoption of Roles by Primary Care Providers During Implementation of The New Chronic Disease Guidelines in Urban Mongolia- A Qualitative Study

    Nov 1, 2016, 00:00

  • Feasibility of Matching-Adjusted Indirect Comparison (MAIC) of Omalizumab (OMA) vs. Mepolizumab (Mepo) in Moderate-to-Severe Asthma

    Nov 1, 2016, 00:00

  • Effectiveness of Clinical Pharmacist Intervention on Direct Medical Cost in Chronic Obstructive Pulmonary Disorder Patients - A Randomized Controlled Study

    Nov 1, 2016, 00:00

  • Suggestion on Critical Illness Insurance in China

    Nov 1, 2016, 00:00

  • Good Cop, Bad Cop; G-BA and Iqwig in Clinical Outcome Evaluations

    Nov 1, 2016, 00:00

  • Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

    Nov 1, 2016, 00:00

  • The Hector Study- Health Economics Study of Codeine And Tramadol Non-Responders – A Sub Population Analysis

    Nov 1, 2016, 00:00

  • Understanding the Policy-Relevant Portion of the Efficient Frontier in Screening Interventions- The Importance of Comparator Strategies

    Nov 1, 2016, 00:00

  • Are Allocation Preferences In Health Care Consistent With A Particular Definition Of Severity? Results From A Random-Sample Survey Of Norwegians

    Nov 1, 2016, 00:00

  • Prescription Trend in Antihypertensive Drugs in Mumbai And Suburbs- A Survey

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • The Impact of Surgical Professional Education- A Review of Clinical and Economic Outcomes

    Nov 1, 2016, 00:00

  • A Patient Level Simulation Model

    Nov 1, 2016, 00:00

  • Key Drivers of HTA Decisions for “Life-Changing” Drugs

    Nov 1, 2016, 00:00

  • Cost Effectivess Analysis for Combination of Aspirin and Warfarin Versus Warfarin Alone in Patients with Heart Valve Prosthesis

    Nov 1, 2016, 00:00

  • Heparin and Related Substances for Treating Diabetic Foot Ulcers

    Nov 1, 2016, 00:00

  • Perioperative Therapies Reducing Homologous Transfusions During Cardiovascular Surgery- A Network Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2016, 00:00

  • Review of Insulin Listing in the National Drug Formulary of Malaysia

    Nov 1, 2016, 00:00

  • A Study on Drug Utilization and Drug Related Proplems Among Anti-Ulcer Patiend Admitted in Teaching Hospital

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Surgical Excision Vs Mohs Micrographic Surgery for Non-Melanoma Skin Cancer

    Nov 1, 2016, 00:00

  • Inflammatory Back Pain- Impact on Working Hours, and Quality of Life at 12 Months

    Nov 1, 2016, 00:00

  • Cost-of-Illness of Metastatic Gastroenteropancreatic Neuroendocrine Tumours In Sweden – A Register-Linkage Population-Based Study

    Nov 1, 2016, 00:00

  • Effective Use of Long-Term Healthcare In Chile- Are International Migrants At Disadvantage of Universal Health Coverage

    Nov 1, 2016, 00:00

  • Oab in Poland - This is Time for A Change

    Nov 1, 2016, 00:00

  • Cost of Sorafenib for Russian Government Drug Provision Program

    Nov 1, 2016, 00:00

  • Sleeping Pills Use Among Adults in Israel

    Nov 1, 2016, 00:00

  • Drug Pricing And Reimbursement Processes In Algeria

    Nov 1, 2016, 00:00

  • Patterns of Index Biologic Drug Registrations To A Pharmacovigilance Register of Psoriasis Patients

    Nov 1, 2016, 00:00

  • The mothif study. Costs of Clotting Factors In Haemophilia A And B- A Review From The Berhlingo Database In Seven Comprehensive Health Care Centres In France

    Nov 1, 2016, 00:00

  • Use of Internet and Reliability of Information Obtained Online Concerning Medication Risks/Safety- Perceptions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)

    Nov 1, 2016, 00:00

  • HCV- Treat Ratio and Governance Footprints. Analysis of Regional Differences in Italy

    Nov 1, 2016, 00:00

  • The Normal Reimbursement Procedure Of The Pharmaceutical Submissions Between 2013 And 2015 In Hungary - Needs And Results

    Nov 1, 2016, 00:00

  • The Impact On Societal Burden Of Changed Uptake Of Hormonal Treatments

    Nov 1, 2016, 00:00

  • Influence of Perceived Risk on Willingness to Pay for Diagnosis of Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • Characteristics Of A Patient Population Recruited Using Social Media (Facebook) Compared With Newspaper Advertising (Daily Mail)

    Nov 1, 2016, 00:00

  • Aligned and Flexible? A Comparative Review of SMC and Nice Decision-Making

    Nov 1, 2016, 00:00

  • Impact and Importance of Real World Data in Asia- A Physician's Perspective

    Nov 1, 2016, 00:00

  • Status of Orphan Drugs and Reimbursement Recommendations and Decisions in Analysed European Countries

    Nov 1, 2016, 00:00

  • The Role and Impact of Evidence Review Group Analyses in the Nice Single Technology Assessment (STA) Process

    Nov 1, 2016, 00:00

  • Viability Of Using Electronic Medical Records From European Countries As Data In Novelty (A Novel Observational Longitudinal Study Of Patients With Asthma And/Or Copd)

    Nov 1, 2016, 00:00

  • Development of a Responder Definition for the Migraine Physical Function Impact Diary (MPFID)

    Nov 1, 2016, 00:00

  • Job Burnout Predictors In Community Pharmacists In Serbia

    Nov 1, 2016, 00:00

  • Budgetary Impact Analysis of Reimbursement Varenicline in the Smoking Cessation Treatment of Patients with Major Depression in Spain

    Nov 1, 2016, 00:00

  • How to Handle Data Quality Issues in EQ-5D-5L Valuation Studies. The Spanish Case

    Nov 1, 2016, 00:00

  • Do Health Technology Agencies Accept Methods for Dealing with Treatment Switching and Immature OS Data?

    Nov 1, 2016, 00:00

  • Characteristics, Resources Utilization And Safety Profile of Patients with Acute Pain- A European Real World Evidence Study

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Platinum Plus Paclitaxel Versus Platinum Plus Cyclophosphamide Among Patients with Early-Stage Ovarian Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Making Sense of Clinical Data Reported in Secondary Conditions- The Epidemiology and Clinical Burden of Hyperglycaemia

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications and Relapse

    Nov 1, 2016, 00:00

  • A Pubmed Based Search on Cost Effectiveness and Health-Related Quality of Life Studies with Respect to Complementary and Alternative Medicines

    Nov 1, 2016, 00:00

  • To what Extent are The Learnings from The Introduction of Biosimilars in Inflammatory Diseases Transferable to The Future Introduction of Biosimilars in Oncology?

    Nov 1, 2016, 00:00

  • The Economic Impact of Tobacco Smoking In The Latin-American Healthcare Systems- A Study Conducted In Seven Countries And Its Extrapolation At The Regional Level

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of The Disease Burden Associated with Hemophilia A In China

    Nov 1, 2016, 00:00

  • Fore! Sweeping Generalisations do not Bowl Over all Cultures… Cultural Adaptation in the Kidney Disease Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • Directly Eliciting Personal Utility Functions From A Convenience Sample Of 30 Health Outcomes Professionals- A Pilot Study

    Nov 1, 2016, 00:00

  • Assure-Csu- Resource Use and Economic Burden in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria in Italy

    Nov 1, 2016, 00:00

  • Assessment of Biosimilar Landscape in Korea, Malaysia, Singapore and Taiwan

    Nov 1, 2016, 00:00

  • Assessment Of Various Factors Influencing Quality Of Life In Pcos Patients Of Northern Telangana Region Of India

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting

    Nov 1, 2016, 00:00

  • Health Resource Use and Cost Under Pay on Fee and Case-Based Payment in Hospitalized Patients with Chronic Obstructive Pulmonary Disease in China

    Nov 1, 2016, 00:00

  • Direct Medical Cost and Healthcare Resource Utilization in Elderly Patients with Type 2 Diabetes Mellitus Among Insured Urban Population in China

    Nov 1, 2016, 00:00

  • A Preliminary Cost-Utility Analysis of Non-Invasive Vagus Nerve Stimulation Therapy in Patients Suffering with Headache and Functional Disorder Multi-Morbidity

    Nov 1, 2016, 00:00

  • Glatiramer Acetate (Ga) Results in Significant Reductions in Annualized Relapse Rate (Arr) and Protective Effect on Disibiltiy Progression- Results From a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- The Evolving Assessment Process

    Nov 1, 2016, 00:00

  • International Reference Pricing Across EU

    Nov 1, 2016, 00:00

  • Pharmacoutilization In Patients Suffering From Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Application of A Value Framework Based on Multiple Criteria Decision Analysis in the Context of Health Technology Assessment- A Series of Case Studies with Decision Makers Across European Countries

    Nov 1, 2016, 00:00

  • A Cross-National Comparison Of The Effect Of Age And Gender On Health-Related Quality Of Life (Hrql)

    Nov 1, 2016, 00:00

  • Simulating Patient-Level Profiles To Capture Patient Heterogeneity In Health-Economic Applications

    Nov 1, 2016, 00:00

  • Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

    Nov 1, 2016, 00:00

  • Gestational Diabetes Screening for Chinese Women- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Which Medical Device for Urinary Incontinence Provides Patient The Higher Quality of Life?

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • Impact of Inadequate Insulin Resuspension (IIR) on Clinical, Patient And Economic Outcomes- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Granulocyte Colony-Stimulating Factor (G-Csf) as Adjunctive Therapy in Cancer Patients with Established Febrile Neutropenia

    Nov 1, 2016, 00:00

  • Cost Analysis of Levofloxacin 750mg During 5 Days Vs Levofloxacin 500mg During 10 Days for the Treatment of Comunity-Acquired Pneumonia Under the Brazilian Public Hospital Perspective

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Treatment Strategies For Multiple Myeloma in Elderly Patients- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Comparative Analysis of The Guidelines for Conducting Hta in Poland and Bulgaria

    Nov 1, 2016, 00:00

  • Will Stem Cells For Heart Failure Be The Next Sofosbuvir Issue?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

    Nov 1, 2016, 00:00

  • The Use of ‘Off The Shelf’ Informative Prior Distributions In Random Effect Network Meta-Analysis Models

    Nov 1, 2016, 00:00

  • Chemotherapy, Cytokines and Cancer-Related Fatigue- A Systematic Review of Quantitative Studies in 1312 Patients

    Nov 1, 2016, 00:00

  • Biosimilar Infliximab- Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris

    Nov 1, 2016, 00:00

  • Spill Over Economic Impacts on Families of Children Receiving Hospital-Based Care

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban Versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Kidney-Related Complications Are Associated With Worse Outcomes Among Hospitalized Children With Autosomal Dominant Polycystic Kidney Disease In The US

    Nov 1, 2016, 00:00

  • Cost And Resource Utilization Among Multiple Sclerosis Patients With Increasing Disability In Latin America

    Nov 1, 2016, 00:00

  • A Prospective Analysis of Adverse Drug Reaction in A Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon

    Nov 1, 2016, 00:00

  • Costs of Perennial Allergic Rhinitis And Asthma Increase with Level of Severity And Level of Disease Control

    Nov 1, 2016, 00:00

  • Using A Smartphone Based Self-Management Platform To Support Medication Adherence And Clinical Consultation In Parkinson’s Disease Results From The Smart-PD Randomised Controlled Trial

    Nov 1, 2016, 00:00

  • Review of Multicriteria Decision Analysis Application for Decision-Making in Oncology

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Bariatric Surgery in Germany, France, Italy and the United Kingdom

    Nov 1, 2016, 00:00

  • Association Between Stages of Change and Medication Adherence Among Diabetic Patients in a Primary Health Care Setting in Qatar- A Preliminary Study

    Nov 1, 2016, 00:00

  • The Impact of Inflammatory Bowel Disease on Work Productivity- Comparison of A Real-World Sample Of Patients With Crohn's Disease And Ulcerative Colitis

    Nov 1, 2016, 00:00

  • Implications of Price Erosion of Docetaxel After Loss of Exclusivity on Cost-Effectivess

    Nov 1, 2016, 00:00

  • The Added Value of Real-World Evidence to Connect Disconnected Networks for Network Meta-Analysis- A Case Study in Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis (MCDA)- Common Tools for Different Needs Supporting Healthcare Decision Making in Spain

    Nov 1, 2016, 00:00

  • Burden of Diverticular Disease- An Observational Analysis Based on Italian Real World Data

    Nov 1, 2016, 00:00

  • Impact of National Orphan Drug Policy and Reimbursement Mechanisms Over the Implementation of Managed Entry Agreements in Select Asia-Pacific Countries

    Nov 1, 2016, 00:00

  • Economic Analysis of Evarrest Sealant Matrix Compared with Standard of Care in Severe Soft Tissue Surgical Bleeding- A France Hospital Perspective

    Nov 1, 2016, 00:00

  • Evaluating The Cost-Benefit of A Cognitive Assessment and Training Program Across A Smart City Population in The UK

    Nov 1, 2016, 00:00

  • Cholesterol Management in the US

    Nov 1, 2016, 00:00

  • The Evaluation Health Education to Elevate Correct Medication Knowledge and Ability in Community

    Nov 1, 2016, 00:00

  • Hepatitis C – Real World Effectiveness of HCV Treatment in Poland

    Nov 1, 2016, 00:00

  • Direct Costs Of Epilepsy In Turkey- A Panel Approach

    Nov 1, 2016, 00:00

  • Facing Challenges for a Cost Comparison of Day Surgical and Inpatient Varicose Vein Surgery

    Nov 1, 2016, 00:00

  • Cost of Treatment of Actinic Keratosis on the Face/Scalp in Sweden

    Nov 1, 2016, 00:00

  • Exploring Determinants Of Polypharmacy In The Elderly Population In Austria

    Nov 1, 2016, 00:00

  • Using Subpopulation Treatment Effect Pattern Plot to Identify More Efficient Resource Allocation Policies

    Nov 1, 2016, 00:00

  • Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan

    Nov 1, 2016, 00:00

  • Proqolid Database- Evolution Of Content, Structure, And Functionalities (2012-2016) - Integration In Eprovide, A New Online Platform Dedicated To Clinical Outcome Assessment (Coa) Research

    Nov 1, 2016, 00:00

  • Criteria Driving Values Assessments in Multiple Sclerosis Medicines

    Nov 1, 2016, 00:00

  • The Accuracy of Patient Self Report in Measuring Continuity of Care in Australia

    Nov 1, 2016, 00:00

  • An Update of Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cells Transplant Patients

    Nov 1, 2016, 00:00

  • In-Licensing as a Business Strategy for Pharmaceutical Companies- A Framework for the Nigerian Industry

    Nov 1, 2016, 00:00

  • A Clinical Literature Review of Coronary Artery Calcification and Current Treatment Outcomes in Japan

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Antibiotics for Moderate-to-Severe Community Acquired Pneumonia (CAP) In Adults- a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Utilization And Cost Of Antimicrobials Used In Medicine And Surgery Departments Of A Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Is there Evidence of a Difference Between Willingness to Pay and Willingness to Accept Thresholds? A Review of Nice Technology Appraisals

    Nov 1, 2016, 00:00

  • key Drivers for Market Penetration of Biosimilars in Europe

    Nov 1, 2016, 00:00

  • Spatial Distribution of the Total Number of Medical Devices in Turkey- A Classification Analysis

    Nov 1, 2016, 00:00

  • Understanding Methodological Differences Between and The Appropriate Application of Oncology Value Frameworks in Healthcare Decision-Making

    Nov 1, 2016, 00:00

  • Statistical Models to Predict Indication of Respiratory Patients Between Asthma and COPD

    Nov 1, 2016, 00:00

  • Medication Adherence And Persistance In Type 2 Diabetes Mellitus (T2dm)- Patients Perspective In Ths Spanish Health Care System

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Different Biologic Agents For Ankylosing Spondylitis Treatment In Russia

    Nov 1, 2016, 00:00

  • Knowledge and Perception of Medicine, Dentistry and Pharmacy Students of Malaysian University Regarding Ebola Virus Disease (EVD)

    Nov 1, 2016, 00:00

  • Innovation - A Value For Health And Growth, An International Study On Market Access Stakes For Therapeutic Innovation

    Nov 1, 2016, 00:00

  • Access To Innovative Medicines In The Czech Republic- Length Of Price And Reimbursement (PR) Procedures

    Nov 1, 2016, 00:00

  • Pharmacists Manpower Analysis In Years 2006-2014 At Minstery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Indirect Costs Genereted By Absenteeism Associated with Sclerosis Multiplex In Poland

    Nov 1, 2016, 00:00

  • A Parallel Observational and Prospective Study on Pharmacoeconomic Analysis and Prescribing Pattern of Antibiotics in Infectious Diseases

    Nov 1, 2016, 00:00

  • Humanistic and Economic Outcomes of Pharmacist-Provided Medication Reviews in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Real Life Data Demonstrate Significant Reductions In HBA1C In T2DM Patients Switching From Other Insulins To Insulin Degludec

    Nov 1, 2016, 00:00

  • Burden of Illness in Patients with Elevated High-Sensitivity C-Reactive Protein Levels and a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Treatment Comparative Effectiveness In Rare Diseases- The Case of Transthyretin Familial Amyloid Polyneuropathy Survival

    Nov 1, 2016, 00:00

  • Launching Novel Antibiotics- Access Opportunities and Resistance in European Markets

    Nov 1, 2016, 00:00

  • Attribute Development Using Continuous Stakeholder Engagement to Prioritize Treatment Decisions- A Framework for Patient-Centered Research

    Sep 1, 2016, 00:00

  • Economic Impact of Integrated Care Models for Patients with Chronic Diseases- A Systematic Review

    Sep 1, 2016, 00:00

  • A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research- The Key Principles for Informing Coverage Decisions

    Sep 1, 2016, 00:00

  • The Capability Approach- A Critical Review of Its Application in Health Economics

    Sep 1, 2016, 00:00

  • Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy

    Sep 1, 2016, 00:00

  • Did It Matter That the Cancer Drugs Fund Was Not NICE? A Retrospective Review

    Sep 1, 2016, 00:00

  • Response to Editorial- Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • When Future Change Matters- Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices

    Sep 1, 2016, 00:00

  • A Systematic Review of Health Economic Evaluation Studies Using the Patient’s Perspective

    Sep 1, 2016, 00:00

  • A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies

    Sep 1, 2016, 00:00

  • Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30

    Sep 1, 2016, 00:00

  • International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions

    Sep 1, 2016, 00:00

  • Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life

    Sep 1, 2016, 00:00

  • Decision Modeling for Cost-Utility Analysis

    Sep 1, 2016, 00:00

  • Developing a Patient-Centered Benefit-Risk Survey- A Community-Engaged Process

    Sep 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in France—Accounting for Indirect Protection

    Sep 1, 2016, 00:00

  • Adherence to Self-Care Behaviors among Patients with Type 2 Diabetes—The Role of Risk Preferences

    Sep 1, 2016, 00:00

  • First and Foremost Battle the Virus- Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • Table of Contents

    Sep 1, 2016, 00:00

  • Increasing Patient Involvement in Drug Development

    Sep 1, 2016, 00:00

  • Financing a Cure for Diabetes in a Multipayer Environment

    Sep 1, 2016, 00:00

  • Copyright/Subscription

    Sep 1, 2016, 00:00

  • Instructions for Authors

    Sep 1, 2016, 00:00

  • Patient Preferences in Regulatory Benefit-Risk Assessments- A US Perspective

    Sep 1, 2016, 00:00

  • Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction- A Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • Regulatory Decision Making in Canada—Exploring New Frontiers in Patient Involvement

    Sep 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Sep 1, 2016, 00:00

  • Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions- The European Union Perspective

    Sep 1, 2016, 00:00

  • Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease- Are Current Models Suitable to Evaluate Personalized Medicine?

    Sep 1, 2016, 00:00

  • Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence- The Psychometric Performance of the ICECAP-A and the EQ-5D-5L

    Sep 1, 2016, 00:00

  • Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database

    Sep 1, 2016, 00:00

  • Clinical Guidelines- A NICE Way to Introduce Cost-Effectiveness Considerations?

    Jul 1, 2016, 00:00

  • Health or Happiness? A Note on Trading Off Health and Happiness in Rationing Decisions

    Jul 1, 2016, 00:00

  • Power and Sample Size Calculations in Clinical Trials with Patient-Reported Outcomes under Equal and Unequal Group Sizes Based on Graded Response Model- A Simulation Study

    Jul 1, 2016, 00:00

  • Development of Seasonal Influenza Vaccination Recommendations- Relevance and Influence of the Evidence on the Decision-Making Process in France and The Netherlands

    Jul 1, 2016, 00:00

  • Breakthrough Cancer Pain- Ten Commandments

    Jul 1, 2016, 00:00

  • A Framework for Developing the Structure of Public Health Economic Models

    Jul 1, 2016, 00:00

  • Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C

    Jul 1, 2016, 00:00

  • Instructions for Authors

    Jul 1, 2016, 00:00

  • Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy

    Jul 1, 2016, 00:00

  • A PROMIS Measure of Neuropathic Pain Quality

    Jul 1, 2016, 00:00

  • Predicting the Burden of Revision Knee Arthroplasty- Simulation of a 20-Year Horizon

    Jul 1, 2016, 00:00

  • A Tale of Two Thresholds- A Framework for Prioritization within the Cancer Drugs Fund

    Jul 1, 2016, 00:00

  • Cost-Effectiveness and Clinical Practice Guidelines- Have We Reached a Tipping Point?—An Overview

    Jul 1, 2016, 00:00

  • On the Estimation of the Cost-Effectiveness Threshold- Why, What, How?

    Jul 1, 2016, 00:00

  • Cholinesterase Inhibitor Utilization- The Impact of Provincial Drug Policy on Discontinuation

    Jul 1, 2016, 00:00

  • Table of Contents

    Jul 1, 2016, 00:00

  • Copyright/Subscription

    Jul 1, 2016, 00:00

  • About the Reliability of the Critical Review to Investigate the Generalizability of Economic Evaluations Conducted in Italy

    Jul 1, 2016, 00:00

  • Challenges in Measuring Cost and Value in Oncology- Making It Personal

    Jul 1, 2016, 00:00

  • Health Technology Assessment for Molecular Diagnostics- Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group

    Jul 1, 2016, 00:00

  • How Many Alternatives Can Be Ranked? A Comparison of the Paired Comparison and Ranking Methods

    Jul 1, 2016, 00:00

  • Estimating the Medical Care Costs of Obesity in the United States- Systematic Review, Meta-Analysis, and Empirical Analysis

    Jul 1, 2016, 00:00

  • Comparison of Value Set Based on DCE and/or TTO Data- Scoring for EQ-5D-5L Health States in Japan

    Jul 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76 (current)
  • 77
  • 78
  • 79
  • 80
  • »